A comparison of aralkylamines and aralkylguanidines as antagonists of adrenergic neurone blockade.
D000588:Amines / Q000494:pharmacology*; D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D001763:Blepharoptosis / Q000139:chemically induced* / Q000188:drug therapy*; D002415:Cats; D002746:Chlorpromazine / Q000494:pharmacology; D002794:Choline / Q000494:pharmacology; D004336:Drug Antagonism; D004558:Electric Stimulation; D006145:Guanethidine / Q000494:pharmacology; D006146:Guanidines / Q000494:pharmacology*; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects*; D009206:Myocardium / Q000378:metabolism*; D009541:Nictitating Membrane / Q000187:drug effects*; D009638:Norepinephrine / Q000378:metabolism; D010393:Pempidine / Q000494:pharmacology; D010425:Pentolinium Tartrate / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D011984:Sensory Receptor Cells / Q000187:drug effects*; D013564:Sympathetic Nervous System / Q000502:physiology; D013565:Sympatholytics / Q000494:pharmacology*; D014992:Xylenes / Q000494:pharmacology
D000588:Amines; D006146:Guanidines; D013565:Sympatholytics; D014992:Xylenes; D010643:Phenoxybenzamine; D012110:Reserpine; D010425:Pentolinium Tartrate; D000661:Amphetamine; D010393:Pempidine; D002794:Choline; D002746:Chlorpromazine; D009638:Norepinephrine; D010646:Phentolamine; D006145:Guanethidine